SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate Change

3 Sep 2018 07:00

RNS Number : 4833Z
TP ICAP PLC
03 September 2018
Β 

Β 

Directorate Change

Β 

London, 3 September 2018: TP ICAP plc, the world's largest interdealer broker, is pleased to announce the appointment of Philip Price as an Executive Director, with immediate effect.

Β 

Following a review of the balance of Non-Executive versus Executive representation, the Nominations and Governance Committee determined that in order to maintain a sufficient contribution from the Executive team, Philip Price, who is TP ICAP's Group General Counsel and Global Head of Compliance, would be appointed to the Board as an Executive Director.

Β 

Mr Price has extensive experience in the legal and regulatory aspects of financial services. Having worked in London and Hong Kong, he qualified as a solicitor at CMS in 1990 and subsequently joined Tiphook plc rising to the position of General Counsel and Company Secretary. He was Group Legal Adviser at Dresdner Kleinwort Wasserstein from 1995 to 1997 and was Managing Director and Head of EMEA Corporate Legal Services at UBS AG from 1997 to 2006. He was based in Monaco as General Counsel and COO at SRM Global Fund between 2006 and 2009 and was subsequently Company Secretary and General Counsel at Candover Investments plc from 2009 to 2012. Prior to joining Tullett Prebon plc in 2015 he was a partner and General Counsel at Arle Capital between 2012 and 2014.

Β 

There is no other information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to this appointment.

Β 

Rupert Robson, Group Chairman, said: "I would like to welcome Philip to the Board. Given the increasingly complicated and fast paced regulatory environment in which we operate, we are certain to benefit from his considerable and wide-ranging experience. He has already proven himself an invaluable adviser to the Board as Group General Counsel and Global Head of Compliance, and we are fortunate to now be able to draw on his expertise in an Executive capacity."

Β 

Enquiries:

Β 

Jamie Dunkley, Group Media Relations DirectorTP ICAP plcjamie.dunkley@tpicap.com+44 (0) 20 7200 7524

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOAEAKPFDLXPEFF
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:25 pmRNSDirector/PDMR Shareholding
22nd May 202612:45 pmRNSHolding(s) in Company
13th May 20264:12 pmRNSResult of AGM
13th May 20264:12 pmRNSDirectorate change
13th May 20267:00 amRNSTrading Statement
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20269:00 amRNS2025 Annual Report and Notice of 2026 AGM
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20269:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:05 amRNSLaunch of sixth share buyback programme of £80m
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
5th Nov 20257:00 amRNSTrading Statement
2nd Oct 202510:15 amRNSDirector Declaration
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 202510:30 amRNSHolding(s) in Company
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:30 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:50 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.